SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : EYES (Vision Twenty-One, Inc.)
EYES 4.140-5.0%Aug 30 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: 007 who wrote (49)5/11/1998 2:27:00 PM
From: Andy Jones  Read Replies (1) of 129
 
In terms of relative value, EYES does a great job. I checked Bloomberg this morning, which gave me the following data:
Eyes vs. Industry average
price/sales 1.09 vs. 3.8
price/book 1.6 vs. 4
price/ebitda 21.6 vs. 24.5
sales growth 488 vs. 119
P/e 107 vs. 58.6
p/e implied 15.2 vs. ?
(but EYES forward looking p/e, based on 8.5/.56 = 15.2 (cf. Wheat First Union lowered estimates as of 5/11/98)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext